C-Path’s TRxA announces $250,000 grant for drug development project on antibiotic-resistant gram-negative bacteria
TUCSON, Ariz. August 13, 2024– Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today that Kenneth Keiler, Ph.D., Professor...
